To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...
Adjuvant radiotherapy could substantially reduce risk for locoregional recurrence for patients with advanced muscle-invasive ...
Researchers have identified in a new study that perioperative dynamic alterations in systemic inflammatory markers are highly ...
MIBC requires a multimodal treatment approach, with radical cystectomy as the gold standard and bladder-sparing options for select patients. Adjuvant immunotherapies, such as nivolumab and ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
Post-surgery radiation slashes the risk of locoregional recurrence in patients with advanced muscle-invasive bladder cancer — but what is its role alongside immunotherapy?
News-Medical.Net on MSN
Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...
Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...
In a recent conversation with CURE, Hensley discussed the current treatment landscape of non-muscle-invasive bladder cancer, as well as how patient counseling is guided by individual risk factors.
A research study led from India, the 'Bladder Adjuvant Radiotherapy (BART) trial', is the largest randomized trial in the ...
A groundbreaking Indian study, the BART trial, highlights that radiation therapy post-surgery safely reduces pelvic relapse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback